Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Omri Zveik

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
JAMA Neurology|September 23, 2021
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With OcrelizumabLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|January 15, 2026
Chronic stress amplifies multidimensional disease activity in multiple sclerosis patients: A year-long within-person analysisOmri Zveik-Lavi, Dvir Green, Ariel Rechtman, et al.
Brain, Behavior, and Immunity|August 23, 2024
Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis modelTal Ganz, Nina Fainstein, Paschalis Theotokis, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Annals of Neurology|March 4, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with OcrelizumabLivnat Brill, Catarina Raposo, Ariel Rechtman, et al.
Glia|August 23, 2023
Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSTal Ganz, Omri Zveik, Nina Fainstein, et al.
JAMA Neurology|September 23, 2021
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With OcrelizumabLivnat Brill, Ariel Rechtman, Omri Zveik, et al.
Multiple Sclerosis and Related Disorders|January 15, 2026
Chronic stress amplifies multidimensional disease activity in multiple sclerosis patients: A year-long within-person analysisOmri Zveik-Lavi, Dvir Green, Ariel Rechtman, et al.
Brain, Behavior, and Immunity|August 23, 2024
Targeting CNS myeloid infiltrates provides neuroprotection in a progressive multiple sclerosis modelTal Ganz, Nina Fainstein, Paschalis Theotokis, et al.
Pageof 3